312 related articles for article (PubMed ID: 30665442)
1. Elevated expression of Gab1 promotes breast cancer metastasis by dissociating the PAR complex.
Wang X; Peng J; Yang Z; Zhou PJ; An N; Wei L; Zhu HH; Lu J; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2019 Jan; 38(1):27. PubMed ID: 30665442
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
3. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
4. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
5. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.
Sun W; Zhang Z; Wang J; Shang R; Zhou L; Wang X; Duan J; Ruan B; Gao Y; Dai B; Qu S; Liu W; Ding R; Wang L; Wang D; Dou K
Oncotarget; 2016 Mar; 7(10):11595-608. PubMed ID: 26871477
[TBL] [Abstract][Full Text] [Related]
7. The signaling adaptor GAB1 regulates cell polarity by acting as a PAR protein scaffold.
Yang Z; Xue B; Umitsu M; Ikura M; Muthuswamy SK; Neel BG
Mol Cell; 2012 Aug; 47(3):469-83. PubMed ID: 22883624
[TBL] [Abstract][Full Text] [Related]
8. Microenvironment-induced TIMP2 loss by cancer-secreted exosomal miR-4443 promotes liver metastasis of breast cancer.
Wang J; Zhang Q; Wang D; Yang S; Zhou S; Xu H; Zhang H; Zhong S; Feng J
J Cell Physiol; 2020 Jul; 235(7-8):5722-5735. PubMed ID: 31970775
[TBL] [Abstract][Full Text] [Related]
9. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
10. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
12. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
13. RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.
Wang M; Zhang Y; Xu Z; Qian P; Sun W; Wang X; Jian Z; Xia T; Xu Y; Tang J
Cell Commun Signal; 2020 Aug; 18(1):128. PubMed ID: 32807176
[TBL] [Abstract][Full Text] [Related]
14. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
15. Par-4 activation restrains EMT-induced chemoresistance in PDAC by attenuating MDM-2.
Ahmad SM; Nayak D; Mir KB; Faheem MM; Nawaz S; Yadav G; Goswami A
Pancreatology; 2020 Dec; 20(8):1698-1710. PubMed ID: 33039292
[TBL] [Abstract][Full Text] [Related]
16. SIN1 promotes the proliferation and migration of breast cancer cells by Akt activation.
Wang D; Wu P; Wang H; Zhu L; Zhao W; Lu Y
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27780891
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of TGF‑β‑SMAD‑mediated epithelial‑mesenchymal transition in pro‑metastatic property of PAX6.
Jin M; Gao D; Wang R; Sik A; Liu K
Oncol Rep; 2020 Aug; 44(2):555-564. PubMed ID: 32627030
[TBL] [Abstract][Full Text] [Related]
18. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
Huo X; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncotarget; 2015 Dec; 6(39):41959-75. PubMed ID: 26544623
[TBL] [Abstract][Full Text] [Related]
19. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.
Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G
J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701
[TBL] [Abstract][Full Text] [Related]
20. Heterodimer formation by Oct4 and Smad3 differentially regulates epithelial-to-mesenchymal transition-associated factors in breast cancer progression.
Mandal G; Biswas S; Roy Chowdhury S; Chatterjee A; Purohit S; Khamaru P; Chakraborty S; Mandal PK; Gupta A; de la Mare JA; Edkins AL; Bhattacharyya A
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2053-2066. PubMed ID: 29526821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
